Buscar
01/07/2021
Predictors of severe COVID-19 in kidney transplant recipients in the different epidemic waves: Analysis of the Spanish Registry
Villanego, F, Mazuecos, A, Perez-Flores, IM, Moreso, F, Andres, A, Jimenez-Martin, C, Molina, M, Canal, C, Sanchez-Camara, LA, Zarraga, S, Ruiz-Fuentes, MD, Aladren, MJ, Melilli, E, Lopez, V, Sanchez-Alvarez, E, Crespo, M, Pascual, J. Predictors of severe COVID-19 in kidney transplant recipients in the different epidemic waves: Analysis of the Spanish Registry. AMERICAN JOURNAL OF TRANSPLANTATION. 2021; 21(7)DOI:10.1111/ajt.16579. PMID:33756067. IF:9.369(Q1/1D).
22/09/2022
Clinical and genetic characterization of a cohort of proteinuric patients with biallelic CUBN variants
Domingo-Gallego, A, Pybus, M, Madariaga, L, Pinero-Fernandez, JA, Gonzalez-Pastor, S, Lopez-Gonzalez, M, Simarro-Rueda, E, Quintanilla-Mata, ML, Matoses-Ruiperez, ML, Ejarque-Vila, L, Cornec-Le Gall, E, Guirado, L, Torra, R, Ariceta, G, Ars, E. Clinical and genetic characterization of a cohort of proteinuric patients with biallelic CUBN variants. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022; 37(10)DOI:10.1093/ndt/gfab285. PMID:34610128. IF:6.100(Q1/2D).
29/04/2022
Comparative analysis of tools to predict rapid progression in autosomal dominant polycystic kidney disease
Naranjo, J, Furlano, M, Torres, F, Hernandez, J, Pybus, M, Ejarque, L, Cordoba, C, Guirado, L, Ars, E, Torra, R. Comparative analysis of tools to predict rapid progression in autosomal dominant polycystic kidney disease. Clinical Kidney Journal. 2022; 15(5)DOI:10.1093/ckj/sfab293. PMID:35498884. IF:4.600(Q1/2D).
25/04/2022
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International
Muller, RU, Messchendorp, AL, Birn, H, Capasso, G, Cornec-Le Gall, E, Devuyst, O, van Eerde, A, Guirchoun, P, Harris, T, Hoorn, EJ, Knoers, NVAM, Korst, U, Mekahli, D, Le Meur, Y, Nijenhuis, T, Ong, ACM, Sayer, JA, Schaefer, F, Servais, A, Tesar, V, Torra, R, Walsh, SB, Gansevoort, RT. An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022; 37(5)DOI:10.1093/ndt/gfab312. PMID:35134221. IF:6.100(Q1/2D).
09/03/2022
Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical Trial
Paez-Vega, A, Gutierrez-Gutierrez, B, Aguera, ML, Facundo, C, Redondo-Pachon, D, Suner, M, Lopez-Oliva, MO, Yuste, JR, Montejo, M, Galeano-Alvarez, C, Ruiz-San Millan, JC, Los-Arcos, I, Hernandez, D, Fernandez-Ruiz, M, Munoz, P, Valle-Arroyo, J, Cano, A, Rodriguez-Benot, A, Crespo, M, Rodelo-Haad, C, Lobo-Acosta, MA, Garrido-Gracia, JC, Vidal, E, Guirado, L, Cantisan, S, Torre-Cisneros, J. Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical Trial. CLINICAL INFECTIOUS DISEASES. 2022; 74(5)DOI:10.1093/cid/ciab574. PMID:34228099. IF:11.800(Q1/1D).
25/02/2022
Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study
Aapkes, SE, Bernts, LHP, van den Berg, AP, van den Berg, M, Blokzijl, H, Cantineau, AEP, van Gastel, MDA, de Haas, RJ, Kappert, P, Muller, RU, Nevens, F, Torra, R, Visser, A, Drenth, JPH, Gansevoort, RT. Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study. BMC GASTROENTEROLOGY. 2022; 22(1)DOI:10.1186/s12876-022-02142-y. PMID:35216547. IF:2.400(Q4/9D).
22/02/2022
The ERA Registry Annual Report 2019: summary and age comparisons
Boenink, R, Astley, ME, Huijben, JA, Stel, VS, Kerschbaum, J, Ots-Rosenberg, M, Asberg, AA, Lopot, F, Golan, E, de la Nuez, PC, Camblor, MR, Trujillo-Aleman, S, San Millan, JCR, Mingo, PU, Diaz, JM, Bouzas-Caamano, ME, Artamendi, M, Madre, MA, de Pablos, CS, Roblero, MFS, Zurriaga, O, Stendahl, ME, Bell, S, Idrizi, A, Ioannou, K, Debska-Slizien, A, Galvao, AA, De Meester, JM, Resic, H, Hommel, K, Radunovic, D, Palsson, R, Lassalle, M, Finne, P, Bazaga, MD, Gjorgjievski, N, Seyahi, N, Bonthuis, M, Ortiz, A, Jager, KJ, Kramer, A. The ERA Registry Annual Report 2019: summary and age comparisons. Clinical Kidney Journal. 2022; 15(3)DOI:10.1093/ckj/sfab273. PMID:35211303. IF:4.600(Q1/2D).
08/02/2022
Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?
Hughes, DA, Aguiar, P, Lidove, O, Nicholls, K, Nowak, A, Thomas, M, Torra, R, Vujkovac, B, West, ML, Feriozzi, S. Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?. Orphanet Journal of Rare Diseases. 2022; 17(1)DOI:10.1186/s13023-022-02181-4. PMID:35135579. IF:3.700(Q2/4D).
01/02/2022
Assessment of Tacrolimus Neurotoxicity Measured by Retinal OCT
Ahmadian, KM, Cabanas, NS, Herrera, CC, de Arizon, LF, Mir, MP, Perich, LG, Molas, CF. Assessment of Tacrolimus Neurotoxicity Measured by Retinal OCT. TRANSPLANTATION PROCEEDINGS. 2022; 54(1)DOI:10.1016/j.transproceed.2021.10.013. PMID:34911620. IF:0.900(Q4/9D).
07/01/2022
A Prospective Multicenter Trial to Evaluate Urinary Metabolomics for Non-invasive Detection of Renal Allograft Rejection (PARASOL): Study Protocol and Patient Recruitment
Banas, MC, Bohmig, GA, Viklicky, O, Rostaing, LP, Jouve, T, Guirado, L, Facundo, C, Bestard, O, Grone, HJ, Kobayashi, K, Hanzal, V, Putz, FJ, Zecher, D, Bergler, T, Neumann, S, Rothe, V, Santamaria, ASG, Schiffer, E, Banas, B. A Prospective Multicenter Trial to Evaluate Urinary Metabolomics for Non-invasive Detection of Renal Allograft Rejection (PARASOL): Study Protocol and Patient Recruitment. Frontiers in Medicine. 2022; 8DOI:10.3389/fmed.2021.780585. PMID:35071266. IF:3.900(Q2/4D).
01/01/2022
The Role of Arterial Stiffness in the Estimation of Cardiovascular Risk in Liver Transplant Recipients
Sastre, L, Garcia, R, Gandara, JG, Fernandez-Llama, P, Amor, AJ, Sierra, C, Escude, L, Ruiz, P, Colmenero, J, Ortega, E, Navasa, M, Crespo, G. The Role of Arterial Stiffness in the Estimation of Cardiovascular Risk in Liver Transplant Recipients. Transplantation Direct. 2022; 8(1)DOI:10.1097/TXD.0000000000001272. PMID:34966842. IF:(Q/D).
01/01/2022
The 2019 and 2021 International Workshops on Alport Syndrome
Daga, S, Ding, J, Deltas, C, Savige, J, Lipska-Zietkiewicz, BS, Hoefele, J, Flinter, F, Gale, DP, Aksenova, M, Kai, H, Perin, L, Barua, M, Torra, R, Miner, JH, Massella, L, Ljubanovic, DG, Lennon, R, Weinstock, AB, Knebelmann, B, Cerkauskaite, A, Gear, S, Gross, O, Turner, AN, Baldassarri, M, Pinto, AM, Renieri, A. The 2019 and 2021 International Workshops on Alport Syndrome. EUROPEAN JOURNAL OF HUMAN GENETICS. 2022; 30(5)DOI:10.1038/s41431-022-01075-0. PMID:35260866. IF:5.200(Q1/2D).
01/01/2022
CKD: The burden of disease invisible to research funders
Roger, M, Gallego, RH, Jimenez, VM, Perez, JCR, Furlano, M, Atxer, LS, Zurro, DG, Casabona, CMR, Gomez, CG, Bermudez, PP, Armisen, MA, Lopez, SA, Porras, IG, Ruiz, JG, Orgaz, JMM, Baron, MM, Ortiz, PD, de la Fuente, GD, Gili, BQ, Fresnedo, GF, Cabrera, SS, Contreras, JP, Pelicano, MB, Blanca, AM, Portillo, MR, Alvarez, JES, Romeo, MJS, Perez, MG, Diezhandino, MG, Marrero, DH, Campo, CF, Garcia, EM, Carmona, DGC, Ramirez, AT, Bellvis, LM, Haym, MB, Gomez, MB, Martinez, JMC, Garrit, JMC, Garrido, RS, Delgado, JB, Marimont, MB, Munoz, MOV, Villares, JMP, Velazquez, AS, Bonet, LA, Bravo, MAG, Mateos, FJM, Amador, MM, Minano, JAP, Belmonte, AA, Jover, AS, Rituerto, DC, Sanchez, FP, Arenas, MD, Hernandez, RM, Serrano, BM, Ortiz, A, Sanz, AB, Ramos, AM, Cordoba-David, G, Garcia-Jimenez, J, Fontecha-Barriuso, M, Guerrero-Mauvecin, J, Lopez-Diaz, AM, Sanchez-Nino, MD, Valino-Rivas, L, Cuarental, L, Ribagorda, M, Pintor-Chocano, A, Favero, C, Alvarez-Llamas, G, Catalina, MC, Fernandez-Fernandez, B, Perez-Gomez, MV, de Montaner, ERA, Prado, RF, Rivera, JR, Verde, AMR, Carriazo, S, Luis-Lima, S, Sanchez-Rodriguez, J, Sanchez, SP, Ortega, MR, Parra, EG, Mateos, SR, Ortiz, PJC, Exposito, LM, Tejera-Munoz, A, Marchant, V, Tejedor-Santamaria, L, Agilar, MA, Diekmann, F, Genis, BB, Salinas, FO, Bajo, MJR, Maneus, EB, Guillen, MA, Juarez, JR, Rodriguez, ML, Vicente, IR, Pelicano, JMB, Porras, LFQ, Aguiar, PVA, Font, MX, Andujar, AM, Cucchiari, D, Marrah, EM, Plana, JMC, Pineiro, GJ, Salgado, CM, Martin, AIM, Hernandez, FJL, Balboa, NE, Vicente, MP, Calvo, IF, Gonzalez, LR, Vicente, LV, Martinez, SMS, Paso, AGC, Garriel, MP, Lopez, JJV, Palacios, AMC, Saenz, DS, Garcia, PG, Bonilla, JLA, Rodriguez, MAF, Galan, AD, Marcos, EM, Perez-Aradros, JC, San Jose, RM, Zelaya, FM, Panades, ES, Salido, JA, Balcells, RT, Criach, EA, Encarnacion, MD, Perich, LG, Girol, CC, Terroba, YA, Oliveras, MP, Vila, LE, Cabanas, NS, Molas, CF, Torres, IS, Pelaez, SL, Serra, CR, Torres, CC, Fajardo, JPT, Lahuerta, JIH, Herranz, VM, Malo, AM, Castaneda, JRM, Ortiz, MER, Moreno, JMM, Bermudez, AIR, Olmo, RS, Pavon, FG, Peregrin, CM, Tejero, EA, Villalba, IL, Munoz, AC, De Mier, MVPR, Martos, CMP, Baltanas, RL, Haad, CR, Bartolome, MF, Valdemoros, RL, Serres, FEB, Diaz, MN, Marino, FJJ, Sole, LC, Saborido, MIT, Majoral, JS, Martinez, ML, Calabia, ER, San Millan, JCR, Lopez-Hoyos, M, Benito-Hernandez, A, San Segundo, D, Valero, R, Garcia, EC, De Ona, JG, Llavona, EC, Rodriguez, FS, Gutierrez, RL, Pena, HG, Lopez, V, Sola, E, Cabello, M, Caballero, A, Leon, M, Ruiz, P, Alonso, J, Navarro-Gonzalez, J, Mora-Fernandez, MD, Donate-Correa, J, Martin-Nunez, E, Delgado, NP, Gigarran-Guldris, S, Teruel, JLG, Castelao, AM, Revilla, JMV, Martinez, CM, Stanojevic, MB, Boque, EC, Rosell, MNS, De Lamo, VM, Tocados, JMD, Carrasco, AG, Lopez, MB, Enriquez, MC, Bardaji, AM, Masot, ND, Gomez, AP, Sanjuan, AE, Ortega, AO, Fuentes, RW, Guindo, MDD, Fuentes, MDR, Ravassa, FO, Molina, MC, Tortosa, CLR, Garrido, RGD, Jacobs-Cacha, C, Matamoros, OB, Mateos, FM, Meneghini, MAE, Roig, JS, Betsabe, IT, Larrea, CL, Alvarez, BS, Corte, MDD, Rodrigues-Diez, RR, Vazquez, AL, Rodriguez, SG, Castineira, JRV, Martin, CM, Alvarez, MLS, Iglesias, VC, Borra, JM, Rubio, MAB, Gilsanz, GD, Cabrera, ML, Heffernan, JAJ, Gonzalez, MO, Gonzalez, OC, Garcia, MEG, Martin, CJ, Correa, PS, Ramos, SA, Oliva, ML, Becerra, BR, Cabrera, CV, Mateo, GTG, Villanueva, RS, Garcia, LA, Andia, JBC, Diaz, MN, Martin, JLF, Lopez, NC, Garcia, SP, Montes, CA, Garcia, MR, Luengas, ILM, Alvarez, ES, Arias, LM, Carro, BM, Virgala, JM, Gonzalez, MG, Barreiro, JML, Fontan, MP, Gonzalez, AO, Barja, LMC, Barreiro, AS, Arias, BP, Hernandez, AA, Perez, MP, Varela, JC, Lechuga, JA, Rodriguez, CD, Murias, MG, de la Iglesia, AMB, Pineiro, PB, Eijo, AC, Cachaza, NC, Gonzalez, MV, Blanch, NL, Martinez, AMS, Val, MH, Draibe, JB, Melilli, E, Montero, AM, Perez, NM, Oliveras, XF, Barrio, MC, Santos, JP, Barrera, CB, Saez, MJP, Pachon, MDR, Cabrales, CA, Porras, AB, Garcia, ER, Gonzalez, VP, Mallol, LL, Oliva, MR, Puyol, DR, Torres, MPR, Ongil, SL, Basilio, LC, Centenera, GO, de Miguel, PM, Rodriguez, LF, Nadah, HB, Fernandez, MP, Chamond, MRR, Ortiz, PS, Fernandez, NG, Boillos, AB, Cenarruzabeitia, NV, Seara, MAF, Dorronsoro, ID, Moreno, PM, Lavilla, FJ, Torres, A, Miranda, DM, Hernandez, APR, Redondo, ED, Porrini, E, Caso, MDC, Tamajon, MLP, Hernandez, MR, Rebollo, MSG, Mallen, PD, Gonzalez, AA, Rinne, AMG, Rodriguez, RM, Torres, SE, Sosa, DA, Cabrera, BE, Rodriguez, NZ, Hernandez, AF, Gamboa, MJR, de los Angeles, CCM, Lourdes, PTM, Margarita, RH, Sagrario, GRM, Patricia, DM, Alejandra, AG, Maria, GRA, Rosa, MR, Sara, ET, Diego, AS, Beatriz, EC, Nayara, ZR, Arminda, FH, Jose, RGM, Bermejo, MLG, Lucas, MF, Moreno, EC, Munoz, LS, Huertas, SS, Serrano, EMR, Munoz, MER, Toro, LC, Agudo, CPB, Alvarez, CG, Portoles, J, Marques, M, Rubio, E, Sanchez-Sobrino, B, Garcia-Menendez, E, Fernandez, AL, Benitez, PR, Gonzalez, MAGN, Gallardo, ML, Juarez, GMF, Martinez, EG, Terente, MP, Ribera, AT, Escribano, TC, Fontan, FC, Fernandez, AS, Perez-Monteoliva, NRR, Huerta, EL, Rodriguez, GG, Hernandez, SB, Zamorano, SM, Gomez, JML, Gonzalez, AG. CKD: The burden of disease invisible to research funders. NEFROLOGIA. 2022; 42(1)DOI:10.1016/j.nefro.2021.09.004. PMID:34803202. IF:2.600(Q3/6D).
01/12/2021
Long-term follow-up of renal function in patients treated with migalastat for Fabry disease (vol 28, 100786, 2021)
Bichet, DG, Torra, R, Wallace, E, Hughes, D, Giugliani, R, Skuban, N, Krusinska, E, Feldt-Rasmussen, U, Schiffmann, R, Nicholls, K. Long-term follow-up of renal function in patients treated with migalastat for Fabry disease (vol 28, 100786, 2021). Molecular Genetics and Metabolism Reports. 2021; 29DOI:10.1016/j.ymgmr.2021.100807. PMID:34934630. IF:2.082(Q4/9D).
01/11/2021
Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapy
Goicoechea, M, Gomez-Preciado, F, Benito, S, Torras, J, Torra, R, Huerta, A, Restrepo, A, Ugalde, J, Astudillo, DE, Agraz, I, Lopez-Mendoza, M, de Arriba, G, Corchete, E, Quiroga, B, Gutierrez, MJ, Martin-Conde, ML, Lopes, V, Ramos, C, Mendez, I, Cao, M, Dominguez, F, Ortiz, A. Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapy. NEFROLOGIA. 2021; 41(6)DOI:10.1016/j.nefro.2021.01.002. PMID:33714629. IF:3.084(Q2/5D).
01/11/2021
Protocol for Optimizing the Use of Kidneys From Donors With Seropositivity for Hepatitis C Virus in Seronegative Recipients
Franco, A, Moreso, F, Sancho, A, Esforzado, N, Paul, J, Llorente, S, Crespo, M, Guirado, L, Melilli, E, Roncero, FG. Protocol for Optimizing the Use of Kidneys From Donors With Seropositivity for Hepatitis C Virus in Seronegative Recipients. TRANSPLANTATION PROCEEDINGS. 2021; 53(9)DOI:10.1016/j.transproceed.2021.09.013. PMID:34657711. IF:1.014(Q4/9D).
01/09/2021
Hyporesponsiveness or resistance to the action of parathyroid hormone in chronic kidney disease
Bover, J, Arana, C, Urena, P, Torres, A, Martin-Malo, A, Fayos, L, Coll, V, Lloret, MJ, Ochoa, J, Almaden, Y, Guirado, L, Rodriguez, M. Hyporesponsiveness or resistance to the action of parathyroid hormone in chronic kidney disease. NEFROLOGIA. 2021; 41(5)DOI:10.1016/j.nefro.2020.12.019. PMID:33985858. IF:3.084(Q2/5D).
01/07/2023
Long-term multisystemic efficacy of migalastat on Fabry-associated clinical events, including renal, cardiac and cerebrovascular outcomes
Hughes, DA, Bichet, DG, Giugliani, R, Hopkin, RJ, Krusinska, E, Nicholls, K, Olivotto, I, Feldt-Rasmussen, U, Sakai, N, Skuban, N, Sunder-Plassmann, G, Torra, R, Wilcox, WR. Long-term multisystemic efficacy of migalastat on Fabry-associated clinical events, including renal, cardiac and cerebrovascular outcomes. JOURNAL OF MEDICAL GENETICS. 2023; 60(7)DOI:10.1136/jmg-2022-108669. PMID:36543533. IF:3.600(Q2/3D).
01/06/2023
Post-transplant diabetes mellitus and renal cell cancer after renal transplantation
Porrini, E, Perez, NM, Diaz, JM, Lauzurrica, R, Rodriguez, JO, Torres, IS, Moreso, F, Garrit, JMC, Ruiz, RB, Vilaro, MI, Lima, MXM, Ramchand, SK, Ruiz, JC, de los Rios, FG, Alvarez, CR, Guindo, MDD, Macias, M, Vela, DB, Osuna, A, Bayes-Genis, B, Sanchez, CA, Ruiz, MD, Rodriguez, AER, Rollan, RD, Rinne, FG, Sosa, AJ, Mallen, PD, Rinne, AG, Miranda, DM, Torres, A. Post-transplant diabetes mellitus and renal cell cancer after renal transplantation. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2023; 38(6)DOI:10.1093/ndt/gfac291. PMID:36323457. IF:4.800(Q1/2D).
04/04/2023
Creatine Kinase Elevation in Autosomal Dominant Polycystic Kidney Disease Patients on Tolvaptan Treatment
Rodriguez-Espinosa, D, Broseta, JJ, Bastida, C, Alvarez-Mora, MI, Nicolau, C, Alvarez, C, Agraz-Pamplona, I, Sanchez-Baya, M, Furlano, M, Ruiz, C, Quintana, LF, Pineiro, GJ, Poch, E, Torra-Balcells, R, Blasco, M. Creatine Kinase Elevation in Autosomal Dominant Polycystic Kidney Disease Patients on Tolvaptan Treatment. NEPHRON. 2023; 147(3-4)DOI:10.1159/000526368. PMID:36088902. IF:2.300(Q2/5D).